Conference Summaries: Day Two<BR> Monday, January 31, 2000

The Body Covers: The 7th Conference on Retroviruses and Opportunistic Infections

Conference Summaries: Day Two
Monday, January 31, 2000

Session 29 -- State of the Art Lecture: Management of the HIV-Infected Pregnant Woman
Coverage by Melanie Thompson, M.D.
- L3: Management of the HIV-Infected Pregnant Woman
Session 30 -- State of the Art Lecture: HIV Entry and Its Inhibition
Coverage by Paul Sax, M.D.
- L4: HIV Entry and Its Inhibition
Session 31 -- Primary Infection
Coverage by Mark Holodniy, M.D.
- Slide 211: Early Therapy of Vertical HIV-1 Infection: Evidence for Cessation of Viral Replication and Absence of Virus-Specific Immunity
- Slide 212: Primary Infection with HIV-1 with Reduced Drug Susceptibility Does Not Appear to Result from Point Source Transmission
Session 36 -- Antiviral Therapy: Resistance and Reservoirs
Coverage by Doug Ward, M.D.
- Slide 237: Phenotypic Resistance Testing Significantly Improves Response to Therapy (Tx): A Randomized Trial (VIRA 3001)
- Slide 238: Selection of Antiretroviral Resistance in the Latent Reservoir of Human Immunodeficiency Virus Type 1 during Successful Therapy
Coverage by Seattle Treatment Education Project
Session 37 -- Primary and Secondary Prevention of Opportunistic Infections in the Era of HAART
Coverage by Melanie Thompson, M.D.
Coverage by Seattle Treatment Education Project
- Poster 241: Low Rates of All Opportunistic Infections among Patients with Advanced HIV Disease Responding to Antiretroviral Therapy -- the CPCRA 048 Cohort
Session 38 -- Pathogenesis and Treatment of Mycobacterial Infections
Coverage by Doug Ward, M.D.
- Poster 254: Frequency of Isolation of M. avium complex (MAC) from Marrow in Patients Suspected of Disseminated MAC (DMAC) but with Negative Blood Cultures
- Poster 255: Impact of Combination Antiretroviral Therapy on the Risk of Tuberculosis among Persons with HIV
Session 40 -- Pathogenesis and Treatment of CMV Disease in the Era of HAART
Coverage by Paul Sax, M.D.
- Poster 267: Long-Term Effects of HAART on Morbidity and Mortality in HIV-1-Infected Patients at Risk for CMV Disease
- Poster 273: Multicenter Evaluation of CMV Reactivation in HIV-infected Women at Potential Risk for CMV Disease
Session 43 -- HIV-1 Dementia, PML, and Neurologic Complications of Therapy
Coverage by Rick Stryker, M.D., M.P.H.
Session 48 -- Symposium: Metabolic Complications of Antiviral Therapy
Coverage by Alvan Fisher, M.D.
Session 49 -- Immune Reconstitution in Pediatric HIV-1 Infection
Coverage by Mark Holodniy, M.D.
- Poster 319: Immune Reconstitution and Viral Load Response In Antiretroviral naïve Vertically HIV-Infected Children Enrolled In The PENTA 5 Trial
- Poster 324: Response to Childhood Immunizations in HIV-Infected Children Treated with Potent Combination Antiretroviral Therapy
Session 51 -- Immunotherapy and Treatment Interruption
Coverage by Mark Holodniy, M.D.

STEP Conference Coverage

Hear the Lectures from The 7th Conference on Retroviruses and Opportunistic Infections

Hear the Symposia from The 7th Conference on Retroviruses and Opportunistic Infections

Browse or search the abstracts

Return to The Body's coverage of
The 7th Conference on Retroviruses and Opportunistic Infections.

The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.